SCHEMBL5913827

SCHEMBL5913827

CN(c1ccnc([S+](C)[O-])n1)c1nccc(C(C)(C)C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5262831 0.74 LMNA (0.31) —
SCHEMBL5913801 0.70 — —
SCHEMBL803480 0.69 HRH4 (0.40) —
SCHEMBL5914113 0.68 MEN1 (0.39) —
SCHEMBL5914182 0.65 CKS1B (0.31) —
SCHEMBL5914297 0.64 GABRA1 (0.38) —
SCHEMBL13633692 0.63 UHRF1 (0.33) —
SCHEMBL14200175 0.62 TAAR1 (0.36) —
SCHEMBL24240133 0.61 RPS6KA5 (0.30) —
SCHEMBL13074630 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060069110-A1 Substituted heterocyclic compounds and methods of use AMGEN INC. 2006-03-30 — — US disclosed
Send feedback